| Zack's Small Cap Research thinks this company is "underpriced" and gave it a $9.25 price target! Regenerative medicine is the future, and it comes as no surprise that the biotech space is all over it. Who will be the leading biotech companies utilizing regenerative medicine in the future? That's the million-dollar question but this emerging company has explosive growth potential ahead in this rising arena. The company is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. These allografts are not just any allografts. They are best-in-class perinatal tissue allografts! The company is focused on the diabetic wound care market and the advanced wound care market: two multi-billion-dollar markets that could equate to explosive revenues all while helping patients. Recently the company reported a stellar third quarter where net revenue grew over 200% and gross profit grew 79%! Revenues are skyrocketing, the company has secured a CMS Q code, there are game-changing partnerships, a successful capital raise, and the start of a crucial clinical trial for diabetic foot ulcers… this all reads like a recipe for tremendous shareholder value! Learn how this little-known company may soon become the next biotech darling! |
This message is a PAID ADVERTISEMENT for BioStem Technologies Inc. (OTC: BSEM) from Sideways Frequency. StockEarnings, Inc receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $1,000. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either BioStem Technologies Inc. (OTC: BSEM) or Sideways Frequency. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies Inc. (OTC: BSEM) on Huge Alerts website for additional information about the relationship between Sideways Frequency and BioStem Technologies Inc. (OTC: BSEM).
Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe.
StockEarnings, Inc
33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA
W: 877.6.STOCKS
StockEarnings.com
No comments:
Post a Comment